CMS Interoperability Final Rule, FHIR, and AI Voice in 2026

CMS finalized the Interoperability and Prior Authorization Final Rule (CMS-0057-F) in January 2024. The 2026 CMS-0062-P proposed rule extends FHIR-based electronic prior authorization to drugs. AI voice and chat agents that book appointments, check eligibility, or pre-screen authorizations need to plug into the same FHIR rails.

What the rule says

CMS-0057-F was published January 17, 2024 (89 FR 8758). It applies to Medicare Advantage organizations, Medicaid managed care plans, state Medicaid agencies, CHIP managed care entities, and qualified health plans on the Federally-Facilitated Exchanges. The rule requires impacted payers to:

• Implement and maintain a Patient Access API (HL7 FHIR R4 + USCDI v1) starting January 1, 2027 expansions;
• Implement a Provider Access API for treating providers;
• Implement a Payer-to-Payer API supporting member-data portability;
• Implement a Prior Authorization API (CRD/DTR/PAS IGs) for non-drug items and services beginning January 1, 2027;
• Send PA decisions within 72 hours for expedited and 7 calendar days for standard requests;
• Publicly report PA metrics annually.

CMS-0062-P, published April 14, 2026, extends prior-authorization to drugs via FHIR or NCPDP standards beginning October 1, 2027, with public comment open through June 15, 2026.

What AI voice/chat must do

For AI voice agents in healthcare, the rule turns FHIR from "nice to have" into the integration pattern. An AI agent confirming a referral or pre-screening a prior authorization should call the Provider Access API to read clinical context, the Prior Authorization API to submit and track requests, and the Patient Access API to surface PA status to the patient. The 72-hour and 7-day SLAs mean an agent that makes the right API calls can shorten total cycle time materially.

Closed-loop monitoring is now a requirement: the agent should log every PA submission, status check, and approval/denial outcome, with model-version metadata. That telemetry feeds CMS's annual public reporting and the entity's own audit trail.

CallSphere compliance posture

Explore a live demo and compare current plans to find the right fit for your business.

flowchart LR
A[Caller] --> B[Voice Agent]
B --> C[Patient Access\nFHIR API]
B --> D[Provider Access\nFHIR API]
B --> E[Prior Auth API\nCRD/DTR/PAS]
E --> F[Payer]
F --> G[72h Expedited\n7d Standard]
G --> H[(healthcare_voice\nAudit)]

Compliance checklist

1. Stand up FHIR R4 client libraries against Patient, Provider, Payer-to-Payer, and PA APIs.
2. Implement DTR (Documentation Templates and Rules) workflows in the agent.
3. Track PA submissions, status checks, and outcomes in the audit trail with model metadata.
4. Honor the 72-hour and 7-day decision SLAs by triggering escalations.
5. Surface PA status to patients on demand via Patient Access API queries.
6. Log every API call (request, response, latency) for compliance reporting.
7. Capture USCDI v3 fields where supported alongside USCDI v1 baseline.
8. Stand up the public PA-metrics reporting pipeline.
9. Track CMS-0062-P (drug PA) progression; plan NCPDP integration in parallel.
10. Re-test integration with each payer FHIR-server upgrade.

FAQ

Does CMS-0057-F apply to commercial-only payers? No. It applies to MA, Medicaid managed care, state Medicaid, CHIP, and FFE QHPs.

Are providers in scope? Indirectly — they consume Provider Access and Prior Authorization APIs but are not the regulated entity.

Is OAuth required? Yes, FHIR APIs use OAuth 2.0 with SMART-on-FHIR profiles for patient access.

Can AI agents submit PAs autonomously? Yes if the workflow is documented, providers approve, and the agent records human-in-the-loop confirmations.

Sources

• CMS-0057-F Final Rule: https://www.cms.gov/priorities/burden-reduction/overview/interoperability/policies-regulations/cms-interoperability-prior-authorization-final-rule-cms-0057-f
• CMS-0062-P Proposed Rule: https://www.cms.gov/priorities/burden-reduction/overview/interoperability/policies-regulations/cms-interoperability-standards-prior-authorization-drugs-proposed-rule-cms-0062-p
• HL7 FHIR R4: https://hl7.org/fhir/R4/
• Da Vinci PA Implementation Guides: https://www.hl7.org/about/davinci/
• CMS Electronic Prior Authorization overview: https://www.cms.gov/priorities/electronic-prior-authorization/overview